Procter & Gamble Health P/B Ratio
Procter & Gamble Health P/B ratio. Procter & Gamble Health (PGHL) P/B ratio is 17.6 (High), book value per share ₹308.82 vs Healthcare average P/B of 0.01 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see PGHL stock price BSE.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
PGHL P/B Ratio — Valuation Insights & Book Value Analysis
Procter & Gamble Health price-to-book ratio interpretation, valuation status and historical context — current P/B 17.6 (High). View PGHL annual price range for the annual high/low range and current price position.
- Stock appears overvalued with PB of 17.6, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Trading at premium to sector average PB of 0.01
Procter & Gamble Health P/B Ratio Historical Trend
PGHL annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Analyse PGHL FII DII holdings to track promoter, FII and institutional holdings.
PGHL Historical P/B Ratio — Book Value Per Share & Year-End Price
Procter & Gamble Health annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 17.16 | ₹308.82 | ₹5300.00 | ₹525 | High |
| 2025 | 18.05 | ₹315.88 | ₹5703.00 | ₹537 | High |
| 2024 | 16.55 | ₹316.47 | ₹5238.05 | ₹538 | High |
| 2023 | 11.2 | ₹441.76 | ₹4947.75 | ₹751 | High |
| 2022 | 10.89 | ₹362.94 | ₹3953.00 | ₹617 | High |
PGHL vs Healthcare Peers — P/B Ratio Comparison
Procter & Gamble Health P/B 17.6 vs Healthcare average 0.01, median 0.65 — range -6.55–1.13.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -1.2 | ₹35 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.8 | ₹147 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.18 | ₹47 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |